Federal Guidance Emphasizes Importance of Discussing PFAS Exposure with Patients
The Centers for Disease Control and Prevention (CDC) have issued new guidance encouraging healthcare providers to consider increased blood testing for PFAS, also known as “forever chemicals.” Dr. Aaron Bernstein, Director of CDC’s National Center for Environmental Health, highlighted the necessity for individuals and communities to engage in meaningful conversations with their medical providers about PFAS exposure.
Understanding the Risks of PFAS
PFAS, chemicals prevalent in consumer products like clothing and cookware, have been linked to a range of health issues, including elevated cholesterol, cancer, and pregnancy complications. The CDC’s guidance stresses the importance of evaluating exposure history and test results to mitigate future risks associated with PFAS exposure.
Community Engagement and Water Testing
Most Americans are exposed to PFAS through drinking water, prompting the need for increased monitoring and testing by local water suppliers. While blood tests may aid in exposure reduction or offer peace of mind, they cannot pinpoint the exact source of exposure or directly link to specific health conditions.
Challenges and Future Outlook
Access to PFAS blood testing may vary across regions, with costs ranging into the hundreds of dollars. Furthermore, the evolving landscape of PFAS science underscores the need for ongoing updates and information dissemination from CDC to ensure public health safety.
